1. Home
  2. INDP vs SGD Comparison

INDP vs SGD Comparison

Compare INDP & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • SGD
  • Stock Information
  • Founded
  • INDP 2000
  • SGD 2021
  • Country
  • INDP United States
  • SGD United States
  • Employees
  • INDP N/A
  • SGD N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • SGD
  • Sector
  • INDP Health Care
  • SGD
  • Exchange
  • INDP Nasdaq
  • SGD Nasdaq
  • Market Cap
  • INDP 4.0M
  • SGD 4.4M
  • IPO Year
  • INDP N/A
  • SGD N/A
  • Fundamental
  • Price
  • INDP $2.60
  • SGD $1.00
  • Analyst Decision
  • INDP Strong Buy
  • SGD
  • Analyst Count
  • INDP 1
  • SGD 0
  • Target Price
  • INDP $140.00
  • SGD N/A
  • AVG Volume (30 Days)
  • INDP 67.5K
  • SGD 446.1K
  • Earning Date
  • INDP 11-07-2025
  • SGD 11-14-2025
  • Dividend Yield
  • INDP N/A
  • SGD N/A
  • EPS Growth
  • INDP N/A
  • SGD N/A
  • EPS
  • INDP N/A
  • SGD N/A
  • Revenue
  • INDP N/A
  • SGD $1,536,255.00
  • Revenue This Year
  • INDP N/A
  • SGD N/A
  • Revenue Next Year
  • INDP N/A
  • SGD N/A
  • P/E Ratio
  • INDP N/A
  • SGD N/A
  • Revenue Growth
  • INDP N/A
  • SGD 1570.24
  • 52 Week Low
  • INDP $2.22
  • SGD $0.65
  • 52 Week High
  • INDP $47.60
  • SGD $3.27
  • Technical
  • Relative Strength Index (RSI)
  • INDP 40.51
  • SGD 45.39
  • Support Level
  • INDP $2.45
  • SGD $0.91
  • Resistance Level
  • INDP $3.76
  • SGD $1.09
  • Average True Range (ATR)
  • INDP 0.28
  • SGD 0.10
  • MACD
  • INDP -0.06
  • SGD 0.00
  • Stochastic Oscillator
  • INDP 26.80
  • SGD 62.55

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About SGD Safe and Green Development Corporation

Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe and Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partners with third-party equity investors or other developers.

Share on Social Networks: